Health Costs For Alzheimer's Patients Higher Before Diagnosis
the Psychiatry Advisor take:
Health care costs for people diagnosed with Alzheimer’s disease (AD) increase a year before the diagnosis is even made.
Researchers at the University of Eastern Finland, using data from the Finnish Medication Use and Alzheimer's Disease Study, Medalz, involving over 70,000 AD patients found that most of the health care costs (78-84%) for these patients comes from hospital care.
The costs of drug therapy were analyzed as overall costs, and the costs of hospital days were calculated according to the Finnish health care system's unit costs, which also include the patient's payment contribution.
The difference in health care costs between AD and non-AD patients were highest six months after diagnosis, with AD patients having, on average $5436 higher costs per person, annually. And although the difference evened out after six months, two years after diagnosis, AD patients health care costs stabilized at twice that of non-AD patients, the researchers reported in the Journal of Public Health.
Five years before diagnosis, Alzheimer’s patients had, on average, 1.4 more hospitals days per year than non-AD patients. Two years after diagnosis, that figur jumped to 14.2 more hospital days.
Health care costs for people diagnosed with Alzheimer’s disease increase a year before the diagnosis is even made.
The health care costs of patients diagnosed with Alzheimer's disease (AD) start to increase already one year before the diagnosis, shows a new study from the University of Eastern Finland.
The differences in the health care costs between AD patients and non-AD patients were the greatest during six months following the diagnosis, with AD patients having 5,088 euros higher health care costs per person-year. After the first six months, the differences evened out. Two years after the diagnosis, the health care costs of AD patients stabilized at a level two times higher than that of non-AD patients.
The majority of the health care costs of AD patients, i.e. 78-84%, were caused by hospital care and only a fraction by drug therapy. Anti-dementia drugs initiated after the diagnosis explained the majority of the drug costs
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Cardioprotective Treatment May Reduce Adverse Effects in Schizophrenia
- The Challenges of Identifying Biomarkers of Psychiatric Illness
- Impulsivity in Bipolar Disorder, Borderline Personality Disorder, ADHD
- FDA Approves Powerful New Opioid Despite Criticisms
- Oral Therapy for Suicidal Bipolar Depression Gets Breakthrough Designation
- Cannabis Use in Adolescence Associated With Poorer Mental Health Outcomes
- Updates in Borderline Personality Disorder: Your Questions Answered
- Violent Video Games Tied to Physical Aggression
- Shame Drives Suicidal Ideation Among Veterans With PTSD
- Long-term Healthy Diet Associated With Greater Hippocampal Volumes
- FDA to Ban Most Flavored Electronic Cigarettes
- Predictors of CBT Outcomes Identified in Youths With Anxiety Disorders
- Happy Childhood Memories Associated With Better Health
- FDA Launches MyStudies Mobile App in Effort to Increase Access to Real World Patient Data
- Heart Rate Variability Predicts Treatment Response in Anxious Depression